Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells

Experimental Oncology

Volumn 36, Issue 1, 2014, Pages 9-16

  Hussain, A ^a   Gheewala, T M ^a   Vas, A J ^a   Shah, K ^a   Goala, P ^a   Khan, S ^a   Hinduja, S ^a   Sharma, C ^a  

^a Manipal University   (United Arab Emirates)

Author keywords

Bax; Cisplatin; Combination; Cyclin D1; Synergistic; Wheatgrass

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLIN D1; PLANT EXTRACT; PROTEIN BAX; TRITICUM AESTIVUM EXTRACT; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER INHIBITION; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LYMPHOCYTE; MCF 7 CELL LINE; MITOCHONDRION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRITICUM AESTIVUM; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; UTERINE CERVICAL NEOPLASMS; WHEAT;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL PROLIFERATION; CISPLATIN; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MCF-7 CELLS; PLANT EXTRACTS; TRITICUM; UTERINE CERVICAL NEOPLASMS;

EID: 84901245228     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anand P, Kunnumakkara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25: 2097-116.
2. Gonzalez CA, Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer 2010; 46: 2555-62.
3. Bal DG, Foerster SB, Backman DR, et al. Dietary change and cancer: challenges and future direction. J Nutr 2001; 131: 181S-5.
4. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
5. Tan AC, Konczak I, Sze DM, et al. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer 2011; 63: 495-505.
6. Hussain A, Brahmbhatt K, Priyani A, et al. Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biother Radiopharm 2011; 26: 519-27.
7. Saldanha SN, Tollefsbol TO. The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes. J Oncol 2012; 2012: 192464.
8. Marwaha RK, Bansal D, Kaur S, et al. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study. Indian Pediatr 2004; 41: 716-20. (Pubitemid 38988403)
9. Dey S, Sarkar R, Ghosh P, et al. Effect of wheat grass juice in supportive care of terminally ill cancer patients - a tertiary cancer centre experience from India. J Clin Oncol 2006; 24: 8634.
10. Kulkarni SD, Tilak JC, Acharya R, et al. Evaluation of the antioxidant activity of wheatgrass (Triticum aestivum L.) as a function of growth under different conditions. Phytother Res 2006; 20: 218-27.
11. Hänninen O, Rauma AL, Kaartinen K, et al. Vegan diet in physiological health promotion. Acta Physiol Hung 1999; 86: 171-80.
12. Calzuola I, Giavarini F, Sassi P, et al. Short acidic peptides isolated from wheat sprout chromatin and involved in the control of cell proliferation Characterization by infrared spectroscopy and mass spectrometry. Peptides 2005; 26: 2074-85. (Pubitemid 41584069)
13. Falcioni G, Fedeli D, Tiano L, et al. Antioxidant activity of wheat sprouts extracts in vitro: Inhibition of DNA oxidative damage. J Food Sci 2002; 67: 2918-22. (Pubitemid 35376170)
14. Adom KK, Sorrells ME, Liu RH. Phytochemical profiles and antioxidant activity of wheat varieties. J Agric Food Chem 2003; 51: 7825-34.
15. Blokhina O, Virolainen E, Fagerstedt K. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot 2003; 91: 179-94.
16. Bar-Sela G, Tsalic M, Fried G, et al. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. Nutr Cancer 2007; 58: 43-8.
17. Arya P, Kumar M. Chemoprevention by Triticum aestivum of mouse skin carcinogenesis induced by DMBA and croton oil-association with oxidative status. Asian Pacific J Cancer Prev 2011; 12: 143-8.
18. Ben-Arye E, Schiff E, Steiner M, et al. Wheatgrass in Afifi's garden: sprouting integrative oncology collaborations in the Middle East. J Clin Oncol 2011; 29: 944-6.
19. Aydos OS, Avci A, Ozkan T, et al. Antiproliferative, apoptotic and antioxidant activities of wheatgrass (Triticum aestivum L.) extract on CML (K562) cell line. Turk J Med Sci 2011; 41: 657-663.
20. Hussain A, Harish G, Prabhu SA, et al. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression. Cancer Epidemiol 2012; 36: e387-93.
21. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
22. Alao JP, Lam EW, Ali S, et al. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degrada tion of cyclin D1 in human breast carcinoma cell lines. Clin Cancer Res 2004; 10: 8094-104. (Pubitemid 39587551)
23. Wang AG, Kim SU, Lee SH, et al. Histone deacetylase 1 contributes to cell cycle and apoptosis. Biol Pharm Bull 2005; 28: 1966-70. (Pubitemid 41437091)
24. Krzyzanowska J, Czubacka A, Oleszek W. Dietary phytochemicals and human health. Adv Exp Med Biol 2010; 698: 74-98.
25. Kaminski BM, Weigert A, Brune B, et al. Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death. Cancer Chemother Pharmacol 2011; 67: 1167-78.
26. Alitheen NB, Oon CL, Keong YS, et al. Cytotoxic effects of commercial wheatgrass and fiber towards human acute promyelocytic leukemia cells (HL60). Pak J Pharm Sci 2011; 24: 243-50.
27. Tandon S, Arora A, Singh S, et al. Antioxidant profiling of Triticum aestivum (wheatgrass) and its antiproliferative activity in MCF-7 breast cancer cell line. J Pharm Res 2011; 4: 4601-4.
28. Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 2009; 11: 495-510.
29. Sharma C, Sadrieh L, Priyani A, et al. Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol 2011; 35: 272-8.
30. McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 2009; 8: 10-6.
31. Gopal KV, Wu C, Shrestha B, et al. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks. Neurotoxicol Teratol 2012; 34: 495-504.
32. Mukherjea D, Rybak LP. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics 2011; 12: 1039-50.
33. Alizadehnohi M, Nabiuni M, Nazari Z, et al. The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp. J Venom Res 2012; 3: 22-7.
34. Gonzalez-Sanchez I, Lira-Rocha A, Navarrete A, et al. Synergistic anticancer activity of thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells. Anticancer Res 2012; 32: 5159-65.
35. Karaca B, Atmaca H, Bozkurt E, et al. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. Mol Biol Rep 2012; 40: 3925-33.
36. Mazumder ME, Beale P, Chan C, et al. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells. Anticancer Res 2012; 32: 4851-60.
37. Li QQ, Lee RX, Liang H, et al. Enhancement of cisplatin-induced apoptosis by â-elemene in resistant human ovarian cancer cells. Med Oncol 2013; 30: 424.
38. Dai Z, Nair V, Khan M, et al. Pomegranate extract inhi bits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro. Oncol Rep 2010; 24: 1087-91.
39. Singh T, Sharma SD, Katiyar SK. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS One 2011; 6: e27444.
40. Deepa M, Sureshkumar T, Satheeshkumar PK, et al. Purified mulberry leaf lectin (MLL) induces apoptosis and cell cycle arrest in human breast cancer and colon cancer cells. Chem Biol Interact 2012; 200: 38-44.
41. Liu Z, Li M, Chen K, et al. S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells. Mol Med Report 2012; 5: 439-43.
42. Wang M, Chen S, Wang S, et al. Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer Caco-2 cells. Chin J Physiol 2012; 55: 134-44.
43. Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 2005; 23: 4215-24. (Pubitemid 46211327)
44. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007; 6: 24.
45. Casimiro MC, Pestell RG. Cyclin D1 induces chromosomal instability. Oncotarget 2012; 3: 224-5.
46. Shimonishi S, Muraguchi T, Mitake M, et al. Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells. Nutr Cancer 2012; 64: 473-80.
47. Yang S, Ma J, Xiao J, et al. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis. Anat Rec (Hoboken) 2012; 295: 1260-6.
48. Yu XJ, Han QB, Wen ZS, et al. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells. Cancer Lett 2012; 322: 185-94.
49. Magal SS, Jackman A, Ish-Shalom S, et al. Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J Gen Virol 2005; 86: 611-21. (Pubitemid 40331241)
50. Fecker LF, Geilen CC, Tchernev G, et al. Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. J Invest Dermatol 2006; 126: 1366-71. (Pubitemid 43997920)
51. Nunes CT, Miners KL, Dolton G, et al. A noveltumor antigen derived from enhanced degradation of Bax protein in human cancers. Cancer Res 2011; 71: 5435-44.
52. Gupta SC, Reuter S, Phromnoi K, et al. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax. J Biol Chem 2011; 286: 1134-46.
53. Kim TM, Shin SK, Kim TW, et al. Elm tree bark extract inhibits HepG2 hepatic cancer cell growth via pro-apoptotic activity. J Vet Sci 2012; 13: 7-13.
54. Cho MY, Park SY, Park S, et al. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells. Arch Pharm Res 2012; 35: 911-9.
55. Wang S, El-Deiry WS. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. Proc Natl Acad Sci USA 2003; 100:15095-100. (Pubitemid 37518022)
56. Cheng S, Gao N, Zhang Z, et al. Clinical Cancer Research (clincancerres.aacrjournals.org.). Quercetinin-ducestumor-selectiveapoptosis through downregulation of Mcl-1 and activation of Bax. doi: 10.1158/1078-0432. CCR-10-1565/ Clin Cancer Res 2010; 16: 5679-91.
57. Hsu CP, Shih YT, Lin BR, et al. Inhibitory effect and mechanisms of an anthocyanins- and anthocyanidins-rich extract from purple-shoot tea on colorectal carcinoma cell proliferation. J Agric Food Chem 2012; 60: 3686-92.